Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Computerondersteunde zelftraining om de uitvoerende functie te verbeteren (COMPEX)

29 september 2026 bijgewerkt door: Hanne Christensen, Bispebjerg Hospital

Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Studie Overzicht

Gedetailleerde beschrijving

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.

Studietype

Ingrijpend

Inschrijving (Geschat)

307

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Copenhagen, Denemarken
        • Rigshospitalet
      • Copenhagen, Denemarken
        • Bispebjerg Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 100 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • A diagnose of stroke, cardiac arrest or Parkinson's disease.
  • Aged 18 years or older.
  • Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
  • Computer and internet access at home.
  • Providing informed consent.

Inclusion criteria specific for stroke

  • Inclusion within 6 months post-stroke
  • Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
  • Initial stroke severity >/= NIHSS 3.

Inclusion criteria specific for cardiac arrest

• Inclusion within 6 months post ictus.

Inclusion criteria specific for Parkinson's disease

  • Clinical diagnosis of PD.
  • Anti-parkinsonian medical treatment (dopaminergic or other).

Exclusion Criteria:

  • Informed consent not provided
  • Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
  • Not able to participate according to investigator

Exclusion criteria specific for stroke

  • Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
  • Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.

Exclusion criteria specific for cardiac arrest • None

Exclusion criteria specific for PD

• Diagnosis of PD Dementia according to the MDS PD Dementia criteria

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Specific computer-based cognitive rehabilitation

154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Actieve vergelijker: General computer-based cognitive stimulation

154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
CABPad Working Memory Test
Tijdsspanne: After the end of the intervention (8 weeks after baseline)

Test of working memory. The higher score the better (theoretically infinite score)

After the end of the intervention (8 weeks after baseline)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
CABPad Working Memory Test - 3 months follow-up
Tijdsspanne: At follow-up visit 3 months after end of intervention

Test of working memory. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after end of intervention
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

At follow-up visit 3 months after the end of the intervention
Trail Making A
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making A
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Trail Making B
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making B
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
SDMT
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
SDMT
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Phonological verbal fluency test
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Phonological verbal fluency test
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Categorical verbal fluency test
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Categorical verbal fluency test
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Fear questionnaire
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

Directly after the intervention, eight weeks after inclusion
Fear questionnaire
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

At follow-up visit 3 months after the end of the intervention
mrs: Modified Rankin Scale
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
mrs: Modified Rankin Scale
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
EuroQol-5 domain (EQ-5D-5L)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner

Directly after the intervention, eight weeks after inclusion
EuroQol-5 domain (EQ-5D-5L)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner

At follow-up visit 3 months after the end of the intervention
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
Compliance
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Monitoring of total time spent training in minutes

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Tijdsspanne: At follow-up visit 3 months after the end of the intervention

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
2) visual analogue scale (1-10)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more.

Directly after the intervention, eight weeks after inclusion
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Tijdsspanne: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

Directly after the intervention, eight weeks after inclusion

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 juni 2020

Primaire voltooiing (Geschat)

5 november 2026

Studie voltooiing (Geschat)

5 februari 2027

Studieregistratiedata

Eerst ingediend

3 januari 2020

Eerst ingediend dat voldeed aan de QC-criteria

13 januari 2020

Eerst geplaatst (Werkelijk)

14 januari 2020

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

29 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Beschrijving IPD-plan

This is currently undecided

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren